Correlation Between Recursion Pharmaceuticals and SUMITOMO

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and SUMITOMO at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and SUMITOMO into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and SUMITOMO MITSUI FINL, you can compare the effects of market volatilities on Recursion Pharmaceuticals and SUMITOMO and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of SUMITOMO. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and SUMITOMO.

Diversification Opportunities for Recursion Pharmaceuticals and SUMITOMO

-0.29

Correlation Coefficient

Recursion Pharmaceuticals  SUMITOMO

Very good diversification

The 3 months correlation between Recursion and SUMITOMO is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and SUMITOMO MITSUI FINL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SUMITOMO MITSUI FINL and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with SUMITOMO. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SUMITOMO MITSUI FINL has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and SUMITOMO go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and SUMITOMO

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 6.75 times more return on investment than SUMITOMO. However, Recursion Pharmaceuticals is 6.75 times more volatile than SUMITOMO MITSUI FINL. It trades about 0.07 of its potential returns per unit of risk. SUMITOMO MITSUI FINL is currently generating about -0.18 per unit of risk. If you would invest  650.00  in Recursion Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of  107.00  from holding Recursion Pharmaceuticals or generate 16.46% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	78.13%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  SUMITOMO MITSUI FINL

Recursion Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

SUMITOMO MITSUI FINL

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SUMITOMO MITSUI FINL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for SUMITOMO MITSUI FINL investors.

Pair Trading with Recursion Pharmaceuticals and SUMITOMO

The main advantage of trading using opposite Recursion Pharmaceuticals and SUMITOMO positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, SUMITOMO can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SUMITOMO will offset losses from the drop in SUMITOMO's long position.

The idea behind Recursion Pharmaceuticals and SUMITOMO MITSUI FINL pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.